Answers are grounded in this paper and cite their sources.
The management and outcomes of patients with thymoma associated with myasthenia gravis (TAMG) are heterogeneous. Here, we propose a novel classification system based on Masaoka stage and Myasthenia Gravis Foundation of America (MGFA) classification, aiming to guide surgical decisions and perioperative management for these patients. Considering both oncological and neurological factors, this novel TAMG classification provides valuable information on outcome stratification and clinical decision-making for TAMG.
No takes yet. Share an insight, caveat, or question.
Ao et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: